NCT06416345View on ClinicalTrials.gov

Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Parkinson Disease
Interventions
DEVICE

Cue2Walk

24 weeks of using of the Cue2Walk device in the own living environment + 8 weeks of naturalistic follow-up

OTHER

Usual Care

24 weeks of receiving usual care + 8 weeks of using of the Cue2Walk device in the own living environment

Trial Locations (1)

1081HZ

Amsterdam UMC, location VUmc, Amsterdam

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

lead

Amsterdam UMC, location VUmc

OTHER

NCT06416345 - Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease | Biotech Hunter | Biotech Hunter